Table 1. Correlation between CEACAM6 protein expression and clinicopathological features of GC.
| Parameters | cases | CEACAM6 expression | χ2 | P | |
|---|---|---|---|---|---|
| Negative (%) | Positive (%) | ||||
| Tumor diameter | 48.652 | < .001 | |||
| < 5 | 256 | 172 (67.2%) | 84 (32.8%) | ||
| > =5 | 180 | 60 (15.6%) | 120 (84.4%) | ||
| Lauren classification | 172.187 | < .001 | |||
| Diffuse type | 223 | 187 (83.9%) | 36 (16.1%) | ||
| Intestinal type | 213 | 45 (21.1%) | 168 (78.9%) | ||
| TNM stage | 176.634 | < .001 | |||
| I | 90 | 85 (94.4%) | 5 (5.6%) | ||
| II | 104 | 84 (80.8%) | 20 (19.2%) | ||
| III | 173 | 57 (32.9%) | 116 (67.1%) | ||
| IV | 69 | 6(8.7%) | 63 (91.3%) | ||
| Vascular invasion | 121.548 | < .001 | |||
| No | 183 | 106 (57.9%) | 77 (42.1%) | ||
| Yes | 253 | 23 (9.1%) | 230 (90.9%) | ||
| Lymph node metastasis | 104.314 | < .001 | |||
| No | 166 | 140 (84.3%) | 26 (15.7%) | ||
| Yes | 270 | 92 (34.1%) | 178 (65.9%) | ||
| Distant metastasis | 53.594 | < .001 | |||
| No | 375 | 226 (60.3%) | 149 (39.7%) | ||
| Yes | 61 | 6 (9.8%) | 55 (90.2%) | ||